Shengqi Hou

606 total citations
12 papers, 295 citations indexed

About

Shengqi Hou is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Shengqi Hou has authored 12 papers receiving a total of 295 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 3 papers in Oncology and 3 papers in Immunology. Recurrent topics in Shengqi Hou's work include PI3K/AKT/mTOR signaling in cancer (5 papers), Immune Cell Function and Interaction (2 papers) and Ubiquitin and proteasome pathways (2 papers). Shengqi Hou is often cited by papers focused on PI3K/AKT/mTOR signaling in cancer (5 papers), Immune Cell Function and Interaction (2 papers) and Ubiquitin and proteasome pathways (2 papers). Shengqi Hou collaborates with scholars based in United States, China and Netherlands. Shengqi Hou's co-authors include Wen Shen, Andrew Brandmaier, Yi Wang, Rong Guo, Li Liu, Hongbo Hao, Jin‐Xue He, Tingting Gu, Yuxin Yin and Zhong Zhang and has published in prestigious journals such as Journal of Molecular Biology, Molecules and BioEssays.

In The Last Decade

Shengqi Hou

12 papers receiving 293 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shengqi Hou United States 8 230 113 58 36 29 12 295
Haiyang Li China 12 265 1.2× 75 0.7× 68 1.2× 21 0.6× 32 1.1× 31 348
Anjali Geethadevi United States 9 190 0.8× 102 0.9× 79 1.4× 47 1.3× 45 1.6× 17 304
Lakshmipathi Vadlakonda India 5 219 1.0× 64 0.6× 43 0.7× 24 0.7× 32 1.1× 7 299
Sadegh Babashah Iran 8 285 1.2× 178 1.6× 72 1.2× 31 0.9× 29 1.0× 17 375
Jing Lan China 10 315 1.4× 187 1.7× 71 1.2× 38 1.1× 20 0.7× 24 418
Hwajin Son South Korea 3 187 0.8× 82 0.7× 116 2.0× 27 0.8× 28 1.0× 4 290
Terry J. Shackleford United States 6 220 1.0× 64 0.6× 114 2.0× 48 1.3× 42 1.4× 11 320
Antonella Di Costanzo Italy 10 249 1.1× 77 0.7× 68 1.2× 26 0.7× 20 0.7× 11 312

Countries citing papers authored by Shengqi Hou

Since Specialization
Citations

This map shows the geographic impact of Shengqi Hou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shengqi Hou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shengqi Hou more than expected).

Fields of papers citing papers by Shengqi Hou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shengqi Hou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shengqi Hou. The network helps show where Shengqi Hou may publish in the future.

Co-authorship network of co-authors of Shengqi Hou

This figure shows the co-authorship network connecting the top 25 collaborators of Shengqi Hou. A scholar is included among the top collaborators of Shengqi Hou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shengqi Hou. Shengqi Hou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Bartman, Caroline, Shengqi Hou, Fabian Correa, et al.. (2025). Systemic metabolic changes in acute and chronic lymphocytic choriomeningitis virus infection. Molecular Metabolism. 99. 102194–102194. 2 indexed citations
2.
Lieberman, M, Guanxi Qiao, Tiffany R. Emmons, et al.. (2024). CD8+ T cell metabolic flexibility elicited by CD28-ARS2 axis-driven alternative splicing of PKM supports antitumor immunity. Cellular and Molecular Immunology. 21(3). 260–274. 8 indexed citations
3.
Tu, Zhenbo, Shengqi Hou, Yurong Zheng, et al.. (2021). In vivo library screening identifies the metabolic enzyme aldolase A as a promoter of metastatic lung colonization. iScience. 24(5). 102425–102425. 4 indexed citations
4.
Tu, Zhenbo, et al.. (2020). UHRF1 predicts poor prognosis by triggering cell cycle in lung adenocarcinoma. Journal of Cellular and Molecular Medicine. 24(14). 8069–8077. 14 indexed citations
5.
Wang, Melinda, Umberto Tosi, Zhiping Zhou, et al.. (2017). A Murine Model for Quantitative, Real-Time Evaluation of Convection-Enhanced Delivery (RT-CED) Using an 18[F]-Positron Emitting, Fluorescent Derivative of Dasatinib. Molecular Cancer Therapeutics. 16(12). 2902–2912. 15 indexed citations
6.
Brandmaier, Andrew, Shengqi Hou, & Wen Shen. (2017). Cell Cycle Control by PTEN. Journal of Molecular Biology. 429(15). 2265–2277. 81 indexed citations
7.
Brandmaier, Andrew, Shengqi Hou, Sandra Demaria, Silvia C. Formenti, & Wen Shen. (2017). PTEN at the interface of immune tolerance and tumor suppression. Frontiers in Biology. 12(3). 163–174. 17 indexed citations
8.
Hou, Shengqi, et al.. (2017). PTEN in the maintenance of genome integrity: From DNA replication to chromosome segregation. BioEssays. 39(10). 48 indexed citations
9.
Zhang, Zhong, Shengqi Hou, Jin‐Xue He, et al.. (2016). PTEN regulates PLK1 and controls chromosomal stability during cell division. Cell Cycle. 15(18). 2476–2485. 30 indexed citations
10.
12.
Li, Yufei, et al.. (2011). Directed evolution of neutral endoglucanase gene by error-prone PCR.. Journal of Pharmaceutical and Biomedical Sciences. 19(6). 1136–1143. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026